View source for Eprosartan dosage and administration

__NOTOC__
{{Eprosartan}}
{{CMG}}; {{AE}} {{SS}}

==Dosage and Administration==

The usual recommended starting dose of TEVETEN® is 600 mg once daily when used as monotherapy in patients who are not volume-depleted (see WARNINGS, Hypotension in Volume- and/or Salt-Depleted Patients). TEVETEN® can be administered once or twice daily with total daily doses ranging from 400 mg to 800 mg. There is limited experience with doses beyond 800 mg/day.

If the [[antihypertensive]]effect measured at trough using once-daily dosing is inadequate, a twice-a-day regimen at the same total daily dose or an increase in dose may give a more satisfactory response. Achievement of maximum blood pressure reduction in most patients may take 2 to 3 weeks.

TEVETEN® may be used in combination with other [[antihypertensive]]agents such as thiazide [[diuretics]] or [[calcium channel blockers]] if additional blood-pressure-lowering effect is required. Discontinuation of treatment with eprosartan does not lead to a rapid rebound increase in blood pressure.

Elderly, Hepatically Impaired or Renally Impaired Patients

No initial dosing adjustment is generally necessary for elderly or hepatically impaired patients or those with renal impairment. No initial dosing adjustment is generally necessary in patients with moderate and severe [[renal impairment]], with maximum dose not exceeding 600 mg daily.

TEVETEN® may be taken with or without food.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = TEVETEN (EPROSARTAN MESYLATE) TABLET [ABBOTT LABORATORIES] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7cde57a7-eded-4c22-b1c7-98afc5546997 | publisher =  | date =  | accessdate = 20 February 2014 }}</ref>

==References==
{{Reflist}}

{{Angiotensin II receptor antagonists}}

[[Category:Angiotensin II receptor antagonists]]
[[Category:Imidazoles]]
[[Category:Thiophenes]]
[[Category:Benzoic acids]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]